Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced that the company will participate in a number of investor and scientific conferences in June 2022.
JMP Securities Life Sciences Conference:
|
Date: |
Thursday, June 16, 2022 |
|
Venue: |
Lotte Palace Hotel, New York, NY USA |
|
Format: |
In-person live and webcast presentation; One-on-one meetings on June 16 |
|
Time: |
11:00 a.m. ET |
|
Link: |
https://wsw.com/webcast/jmp54/cmmb/1657584 |
|
Information: |
https://jmp-ls.ljfevents-rsvp.com/registration/ |
A replay of the webcast will be available at the Investor section of Chemomab’s website for at least 30 days.
The Extracellular Matrix Pharmacology Congress
|
Date: |
June 23-25, 2022 |
|
Venue: |
Tivoli Congress Center, Copenhagen, Denmark |
|
Format: |
Poster presentation: CCL24 Inhibition by CM-101 Attenuates Extracellular Matrix and Fibrotic Biomarkers in Both Patients and Experimental Murine Models, Abstract ID:155 |
|
Time: |
Poster Session 1, June 23 from 13:00 – 14:15 CET |
|
Presenter: |
Udi Gluschnaider, PhD, Chemomab Project Lead |
|
Information: |
ECM Congress (ecm-congress.org) |
A copy of the poster will be available at the R&D section of Chemomab’s website starting on June 23, 2022.
EASL: The International Liver Congress™ 2022
|
Date: |
June 22-26, 2022 |
|
Venue: |
ExCeL London, London, UK, and virtual |
|
Format: |
Oral poster presentation: Combination of whole liver single cell RNA sequencing and spatial transcriptomics reveals specific cell sub-populations and pathways regulated by CCL24, Abstract Identifier: OS02 |
|
Presenter: |
Raanan Greenman, PhD, Chemomab Project Lead |
|
Time: |
June 23, 2022, 16:45 CET |
|
Session: |
Immune-mediated and cholestatic: Experimental and pathophysiology |
|
Information: |
https://easl.eu/event/international-liver-congress-2022/ |
The presentation will be available at the R&D section of Chemomab’s website starting on June 24, 2022
In addition, Chemomab’s business development team members will be in San Diego, California June 13-16, 2022, participating in the BIO International Convention’s One-on-One Partnering™ event. Registered attendees can click here to log in and schedule a meeting with Chemomab.
